Article
Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.
Haematologica - 1 Jan 2015
Bentley Victoria L, Veinotte Chansey J, Corkery Dale P, Pinder Jordan B, LeBlanc Marissa A, Bedard Karen, Weng Andrew P, Berman Jason N, Dellaire Graham
Abstract excerpt
Cancer therapeutics is evolving to precision medicine, with the goal of matching targeted compounds with molecular aberrations underlying a patient's cancer. While murine models offer a pre-clinical tool, associated costs and time are not compatible with actionable patient-directed interventions. Using the paradigm of T-cell acute lymphoblastic leukemia, a high-risk disease with defined molecular underpinnings,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
